相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses
Baris Ata et al.
HUMAN REPRODUCTION UPDATE (2021)
Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis
Ling Cui et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)
Complex mosaic blastocysts after preimplantation genetic testing: prevalence and outcomes after re-biopsy and re-vitrification
Shuang Zhou et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2021)
Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials
Shaogen Guan et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation
Antonio La Marca et al.
HUMAN REPRODUCTION (2020)
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?
Antonio La Marca et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2019)
Next-generation sequencing analysis of embryos from mosaic patients undergoing in vitro fertilization and preimplantation genetic testing
Keli Luo et al.
FERTILITY AND STERILITY (2019)
Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial
R. Begueria et al.
HUMAN REPRODUCTION (2019)
Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology
Sule Yildiz et al.
FERTILITY AND STERILITY (2019)
Single embryo transfer by Day 3 time-lapse selection versus Day 5 conventional morphological selection: a randomized, open-label, non-inferiority trial
Lanlin Yang et al.
HUMAN REPRODUCTION (2018)
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation
Xiuxian Zhu et al.
FERTILITY AND STERILITY (2017)
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a freeze all'' strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg
Xiuxian Zhu et al.
FERTILITY AND STERILITY (2017)
Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study
Ningling Wang et al.
CLINICAL ENDOCRINOLOGY (2016)
The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
Xiuxian Zhu et al.
MEDICINE (2016)
Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
Xiuxian Zhu et al.
MEDICINE (2015)
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles
Yanping Kuang et al.
FERTILITY AND STERILITY (2014)
Risk evaluation and preimplantation genetic diagnosis in an infertile man with an unbalanced translocation t(10;15) resulting in a healthy baby
De-Hua Cheng et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2012)
GnRH agonists vs antagonists
B. C. Tarlatzis et al.
BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY (2007)
分享论文
